Add Row 
Add 
Add Row 
Add Element 
Impact of Menopause on Multiple Sclerosis Mobility
Recent findings from the University of California, San Francisco have brought to light a significant development for women battling multiple sclerosis (MS). Research indicates that menopause may accelerate the disease's progression, particularly affecting mobility and other functions. According to the study published in the journal Neurology, the post-menopausal phase sees an observable decline in patients’ walking speeds, as well as less noticeable changes in fine motor skills and cognitive capacity.
Hormonal Influence on Multiple Sclerosis Progression
The role of hormones in the journey of MS is not new, but this study renews interest in exploring hormone therapy's potential benefits. Since women make up a staggering 75% of MS patients, and hormonal shifts are known to influence disease dynamics, there is a critical need to understand these interconnections better. Dr. Riley Bove, an associate professor of neurology at UCSF, highlighted that hormonal changes, as seen during puberty or pregnancy, have notable impacts on MS relapse rates and progression.
Need for More Comprehensive Measurement Tools
Challenges lie in accurately gauging the impact of menopause on MS. Prior studies often relied on the Expanded Disability Status Scale (EDSS), focusing primarily on walking but missing other dimensions like dexterity and cognition. To address this, the recent research utilized the MS Functional Composite (MSFC), offering a more holistic view. Results pointed to post-menopausal declines across several areas, signaling nerve cell degeneration.
Unique Benefits of Knowing This Information
Understanding the link between menopause and MS mobility is vital for affected women to make informed health decisions. This knowledge can guide discussions with healthcare providers about potential therapies that might slow disease progression and improve quality of life.
Write A Comment